BSE Live
Dec 30, 16:01Prev. Close
2181.90
Open Price
2176.45
Bid Price (Qty.)
2153.20 (1)
Offer Price (Qty.)
2237.00 (65)
NSE Live
Dec 30, 15:52Prev. Close
2182.00
Open Price
2165.00
Bid Price (Qty.)
2152.50 (1001)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Mankind Pharma (in Rs. Cr.) | Mar 09 | Mar 08 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 81.25 | 64.48 | |
| Diluted EPS (Rs.) | 81.25 | 64.48 | |
| Cash EPS (Rs.) | 84.08 | 67.80 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 224.84 | 203.07 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 224.84 | 203.07 | |
| Dividend / Share(Rs.) | 3.50 | 3.00 | |
| Revenue from Operations/Share (Rs.) | 566.35 | 579.13 | |
| PBDIT/Share (Rs.) | 129.29 | 107.78 | |
| PBIT/Share (Rs.) | 126.46 | 104.47 | |
| PBT/Share (Rs.) | 124.85 | 102.18 | |
| Net Profit/Share (Rs.) | 81.25 | 64.48 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 22.82 | 18.61 | |
| PBIT Margin (%) | 22.32 | 18.03 | |
| PBT Margin (%) | 22.04 | 17.64 | |
| Net Profit Margin (%) | 14.34 | 11.13 | |
| Return on Networth / Equity (%) | 36.13 | 31.75 | |
| Return on Capital Employed (%) | 54.75 | 49.14 | |
| Return on Assets (%) | 23.43 | 19.49 | |
| Total Debt/Equity (X) | 0.02 | 0.04 | |
| Asset Turnover Ratio (%) | 1.93 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 2.13 | 2.20 | |
| Quick Ratio (X) | 1.45 | 1.47 | |
| Inventory Turnover Ratio (X) | 0.22 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 4.30 | 4.65 | |
| Dividend Payout Ratio (CP) (%) | 4.16 | 4.42 | |
| Earnings Retention Ratio (%) | 95.70 | 95.35 | |
| Cash Earnings Retention Ratio (%) | 95.84 | 95.58 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | |
| Retention Ratios (%) | 95.69 | 95.34 | |
| Price/BV (X) | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y